NCT04761146 - A Safety and Efficacy Study of Intra-tumoural Diffusing Alpha Radiation Emitters for the Treatment of Vulva Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2023

Primary Completion Date

September 1, 2025

Study Completion Date

January 1, 2026

Conditions

Vulva Cancer, RecurrentVulvar Squamous Cell CarcinomaVulva Cancer

Interventions

RADIATION

DaRT Diffusing Alpha-emitters Radiation Therapy

DaRT is a brachytherapy treatment comprising stainless-steel 316LVM wires coated with radium-224 (Alpha DaRT seeds). The radioactive seeds are inserted directly into the tumour on the perineum and will be removed after 14 days.

Trial Locations (1)

CB20QQ

RECRUITING

Cambridge University Hospitals NHSFT, Cambridge